secwatch / observer
8-K filed May 26, 2026 12:30 UTC ticker COCP CIK 0001412486
other material confidence high sentiment positive materiality 0.50

Cocrystal Pharma announces discovery of pan-viral inhibitors with <50 nM potency against hantavirus

Cocrystal Pharma, Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001493152-26-025172
form_type
8-K
ticker
COCP
cik
0001412486
company_name
Cocrystal Pharma, Inc.
filed_at
2026-05-26T12:30:22+00:00
discovered_at
2026-05-26T12:35:03.485223+00:00
generated_at
2026-05-26T12:35:14.545916+00:00
sec_items
["7.01", "9.01"]
event_type
other_material
sentiment
positive
materiality_score
0.5
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001493152-26-025172
json_url
https://secwatch.observer/filing/0001493152-26-025172.json
markdown_url
https://secwatch.observer/filing/0001493152-26-025172.md
text_url
https://secwatch.observer/filing/0001493152-26-025172.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1412486/000149315226025172/0001493152-26-025172-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1412486/000149315226025172/form8-k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
Source: SEC EDGAR
accession 0001493152-26-025172

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.